News - Global, Research

Filter

Current filters:

GlobalResearch

Popular Filters

1 to 25 of 66 results

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

Trametinib and dabrafenib gives overall survival benefit compared to vemurafenib

17-07-2014

GlaxoSmithKline says that the Independent Data Monitoring Committee (IDMC) has recommended a Phase III…

BRAFdabrafenibGlobalGSKMetastatic cutaneous melanomaOncologyPharmaceuticalResearchtrametinibvemurafenib

Global regenerative medicine market expected to reach $67 billion by 2020

Global regenerative medicine market expected to reach $67 billion by 2020

15-07-2014

The global regenerative medicine market will reach $67.6 billion by 2020, up from $16.4 billion in 2013…

BiotechnologyGlobalImmunologicalsMarkets & MarketingRegenerative medicineResearchStem cells

inVentiv and ACRES partner to create a global research platform for clinical trials

inVentiv and ACRES partner to create a global research platform for clinical trials

11-07-2014

Two bodies are partnering to fast-track the development of a global system to support responsible conduct…

BiotechnologyClinical researchDrug developmentGlobalGreg KoskiinVentive HealthPharmaceuticalResearch

Incremental innovations in pharma industry spawn life-saving improvements, says think-tank

27-06-2014

Despite claims from critics, incremental innovations by pharmaceutical companies provide great value…

GlobalHealthcarePharmaceuticalResearch

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

27-06-2014

At the inaugural meeting of the newly formed International Council of Biotech Associations (ICBA) which…

Antibiotics and Infectious diseasesBiotechnologyGlobalHealthcareResearch

Global biotechnology industry needs new paradigm for drug R&D

Global biotechnology industry needs new paradigm for drug R&D

24-06-2014

The global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit…

BiotechnologyFinancialGlobalResearch

Regenerative medicine is attractive to investors and could transform health care

Regenerative medicine is attractive to investors and could transform health care

18-06-2014

The majority of treatments for chronic and fatal diseases is palliative or to delay disease progression,…

GlobalPharmaceuticalRegenerative medicineResearch

Bayer pays upfront $50 million for Orion’s prostate cancer candidate ODM-201

Bayer pays upfront $50 million for Orion’s prostate cancer candidate ODM-201

02-06-2014

Finland-based drugmaker Orion Corp has entered into a global partnership with German pharma major Bayer…

BayerGlobalLicensingODM-201OncologyOrion CorpPharmaceuticalResearch

Antibiotic crisis needs united global response, say UK experts

12-05-2014

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale…

Antibiotics and Infectious diseasesGlobalHealthcarePharmaceuticalResearch

Oncology market growth slowing due to fewer breakthroughs and biosimilars, say IMS

06-05-2014

The global oncology drug market reached a value of $91 billion in 2013 but growth in the area is slowing,…

Alternative medicineCancer CareGlobalHealth Medical PharmaIMS HealthOncologyOncologyPharmaceuticalResearch

Need for age-appropriate drug formulations for elderly; report

Need for age-appropriate drug formulations for elderly; report

09-04-2014

Despite the elderly being the fastest-growing segment of the global population, only a few of their treatments…

GlobalHealthcarePharmaceuticalResearch

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

Merck, Ferring and WHO working together to prevent excessive bleeding in women after childbirth

06-04-2014

US pharma giant Merck & Co and privately-held Switzerland-headquartered Ferring Pharmaceuticals have…

carbetocinFerring PharmaceuticalsGlobalMarkets & MarketingMerck & CoPharmaceuticalResearchWomen's Health

Random data or research tool? How social media is viewed by pharma

Random data or research tool? How social media is viewed by pharma

07-03-2014

Here's our take on the week's top stories.

GlobalPharmaceuticalResearch

Report: Reform and legislation is affecting global market access

Report: Reform and legislation is affecting global market access

07-03-2014

Landmark healthcare legislation in developed markets, combined with evolving regulatory trends in emerging…

GlobalMarkets & MarketingPharmaceuticalResearch

Report: R&D market is diversifying innovation, with increased partnerships, mergers and revenue sharing models

06-03-2014

The R&D sector is set to grow at more than 8% driven by new evaluation techniques, according to CPhI…

FinancialGlobalPharmaceuticalResearch

Viiv Healthcare comes out top in global survey of pharma industry reputations

14-02-2014

An independent global study has recorded the latest impressions of the corporate reputation of the world’s…

AbbVieGlobalPharmaceuticalResearchViiV Healthcare

Absence of blockbuster drug launches in 2014 puts R&D productivity at risk

05-02-2014

The past two years have brought a surge of R&D productivity, driving investor confidence and increasing…

GlobalMarkets & MarketingPharmaceuticalResearch

UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes

28-01-2014

Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

27-12-2013

The Alzheimer’s Disease (AD) market will increase slightly from $3.6 billion in 2012 to $3.8 billion…

FinancialGlobalMarkets & MarketingNeurologicalPharmaceuticalResearch

Stelis Biopharma and Pieris link up for novel Anticalin therapeutics in ophthalmology

18-12-2013

Stelis Biopharma (formerly Agila Biotech), a subsidiary of India’s Strides Arcolab, and privately-held…

GlobalLicensingOphthalmicsPharmaceuticalPieris AGResearchStelis BiopharmaStrides Arcolab

Prothena inks deal with Roche, worth a potential $600 million

Prothena inks deal with Roche, worth a potential $600 million

12-12-2013

Biotech firm Prothena has entered into a worldwide collaboration with Swiss drug major Roche to develop…

BiotechnologyGlobalLicensingNeurologicalProthenaPRX002ResearchRoche

Survey aims to discover how early diabetes diagnoses can aid better outcomes

Survey aims to discover how early diabetes diagnoses can aid better outcomes

02-12-2013

A multinational survey of more than 10,000 people with type 2 diabetes has been launched by German family-owned…

Boehringer IngelheimDiabetesEli LillyGlobalPharmaceuticalResearch

Current profitability is a priority for 80% of pharma companies ahead of future

04-11-2013

Pharmaceutical companies are more concerned with getting their existing business right, before implementing…

FinancialGlobalPharmaceuticalResearch

1 to 25 of 66 results

Back to top